Your browser doesn't support javascript.
loading
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas.
Kummar, Shivaani; Gutierrez, Martin E; Chen, Alice; Turkbey, Ismail B; Allen, Deborah; Horneffer, Yvonne R; Juwara, Lamin; Cao, Liang; Yu, Yunkai; Kim, Yeong Sang; Trepel, Jane; Chen, Helen; Choyke, Peter; Melillo, Giovanni; Murgo, Anthony J; Collins, Jerry; Doroshow, James H.
Affiliation
  • Kummar S; Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892, USA. kummars@mail.nih.gov
Eur J Cancer ; 47(7): 997-1005, 2011 May.
Article in En | MEDLINE | ID: mdl-21247755
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Quinazolines / Vascular Endothelial Growth Factor A / Epidermal Growth Factor / Lymphoma / Antibodies, Monoclonal / Neoplasms Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Quinazolines / Vascular Endothelial Growth Factor A / Epidermal Growth Factor / Lymphoma / Antibodies, Monoclonal / Neoplasms Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2011 Document type: Article Affiliation country: Country of publication: